医学
多发性骨髓瘤
限制
重症监护医学
人口
内科学
环境卫生
机械工程
工程类
作者
Wilson I. Gonsalves,Kelly Godby,Shaji Kumar,Luciano J. Costa
摘要
In the era of novel biological agents, multiple myeloma (MM) is often approached as a chronic condition. While survival continues to improve, population-level data indicate that early mortality remains a substantial barrier to advances in MM outcomes. Here we provide "do's and don'ts" management recommendations that may minimize the risk of early mortality and ensure that patients have the opportunity to benefit from the long term impact of new effective MM agents. Such recommendations encompass the early introduction of novel agents even in the presence of comorbidities and advanced age and aggressive management of MM-related complications.
科研通智能强力驱动
Strongly Powered by AbleSci AI